Prostate Cancer Reports


Volume 3 Supplement 9
September 2015

Home > Prostate Cancer Reports > Volume 3, Year 2015 > Supplement 9, September


CONTENTS



DIAGNOSIS AND EVALUATION
PROGNOSIS AND OUTCOMES
TREATMENT





DIAGNOSIS AND EVALUATION



Carroll P, Albertsen PC, Greene K, Babaian RJ, Carter HB, Gann PH, Han M, Ann Kuban DA, Sartor AO, Janet L. Stanford JL, Zietman A.
PSA Testing for the Pretreatment Staging and Posttreatment Management of Prostate Cancer: 2013 Revision of 2009 Best Practice Statement
American Urologic Association, Education, Guidelines & Policies,
Best Practice Statements
Source | Abstract | Full text



PROGNOSIS AND OUTCOMES



Variables as prognosis predictors


Positive biopsy cores


Freedland SJ, Csathy GS, Dorey F, Aronson WJ.
Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score.
J Urol. 2002 Feb;167(2 Pt 1):516-20.
Source | Abstract | Similar articles




Positive surgical margins


De La Roca RL, Da Cunha IW, Bezerra SM, Da Fonseca FP.
Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
Int Braz J Urol. 2014 May-Jun;40(3):306-15. doi: 10.1590/S1677-5538.IBJU.2014.03.03.
Source | Abstract | Full text | Similar articles




Postoperative PSA following RP


Ciatto S.
Editorial comment on: prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.
Eur Urol. 2010 Apr;57(4):630. doi: 10.1016/j.eururo.2009.03.079. Epub 2009 Apr 3.
Source | Abstract | Full text | Similar articles




Doherty AP, Bower M, Smith GL, Miano R, Mannion EM, Mitchell H, Christmas TJ.
Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival.
Br J Cancer. 2000 Dec;83(11):1432-6. Epub 2000 Nov 14.
Source | Abstract | Full text | Similar articles




Eisenberg ML, Davies BJ, Cooperberg MR, Cowan JE, Carroll PR.
Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.
Eur Urol. 2010 Apr;57(4):622-9. doi: 10.1016/j.eururo.2009.03.077. Epub 2009 Apr 3.
Source | Abstract | Full text | Similar articles




Hong SK, Park HZ, Lee WK, Kim DS, Lee JS, Doo SH, Jeong SJ, Yoon CY, Byun SS, Lee SE.
Prognostic significance of undetectable ultrasensitive prostate-specific antigen nadir after radical prostatectomy.
Urology. 2010 Sep;76(3):723-7. doi: 10.1016/j.urology.2010.03.081. Epub 2010 Jul 1.
Source | Abstract | Similar articles




Inoue H, Nishimura K, Yamaguchi S, Nonomura N, Hara T.
Prostate-specific antigen measured 3 months after radical prostatectomy as a new predictor of biochemical recurrence.
Int J Clin Oncol. 2015 Feb;20(1):171-5. doi: 10.1007/s10147-014-0681-7. Epub 2014 Mar 21.
Source | Abstract | Similar articles




Malik RD, Goldberg JD, Hochman T, Lepor H.
Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence.
Eur Urol. 2011 Sep;60(3):548-53. doi: 10.1016/j.eururo.2011.05.036. Epub 2011 May 26.
Source | Abstract | Full text | Similar articles




Ost P, Bossi A, De Meerleer G.
Re: Michael L. Eisenberg, Benjamin J. Davies, Matthew R. Cooperberg, et al. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol 2010;57:622-30.
Eur Urol. 2010 Sep;58(3):e33; author reply e34-5. doi: 10.1016/j.eururo.2010.05.006. Epub 2010 May 20.
Source | Abstract | Full text | Similar articles




Sakai I, Harada K, Kurahashi T, Muramaki M, Yamanaka K, Hara I, Inoue TA, Miyake H.
Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.
Urol Int. 2006;76(3):227-31.
Source | Abstract | Similar articles




Shen S, Lepor H, Yaffee R, Taneja SS.
Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.
J Urol. 2005 Mar;173(3):777-80.
Source | Abstract | Full text | Similar articles




Semjonow A.
Editorial comment on: prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.
Eur Urol. 2010 Apr;57(4):629-30. doi: 10.1016/j.eururo.2009.03.078. Epub 2009 Apr 3.
Source | Abstract | Full text | Similar articles




Vesely S, Jarolim L, Duskova K, Schmidt M, Dusek P, Babjuk M.
The use of early postoperative prostate-specific antigen to stratify risk in patients with positive surgical margins after radical prostatectomy.
BMC Urol. 2014 Oct 2;14:79. doi: 10.1186/1471-2490-14-79.*
Source | Abstract | Full text | Similar articles




Walsh PC.
Re: Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.
J Urol. 2005 Oct;174(4 Pt 1):1500-1; author reply 1501.
Source | Abstract | Similar articles

TREATMENT



Decision making


Koppie TM, Grossfeld GD, Nudell DM, Weinberg VK, Carroll PR.
Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?
J Urol. 2001 Jul;166(1):111-5.
Source | Abstract | Similar articles




Choo R, Morton G, Danjoux C, Hong E, Szumacher E, DeBoer G.
Limited efficacy of salvage radiotherapy for biopsy confirmed or clinically palpable local recurrence of prostate carcinoma after surgery.
Radiother Oncol. 2005 Feb;74(2):163-7. Epub 2004 Dec 15.
Source | Abstract | Similar articles




Choo R, Hruby G, Hong J, Bahk E, Hong E, Danjoux C, Morton G, DeBoer G.
(IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy.
Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):269-76.
Source | Abstract | Similar articles




Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, Scardino PT, Eastham JA, Zelefsky MJ.
Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):112-8. doi: 10.1016/j.ijrobp.2011.10.077. Epub 2012 Jan 31.
Source | Abstract | Similar articles




MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW.
Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
Urology. 2004 Oct;64(4):760-4.
Source | Abstract | Similar articles




Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW.
Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy.
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1530-5.
Source | Abstract | Similar articles




Quero L, Mongiat-Artus P, Ravery V, Maylin C, Desgrandchamps F, Hennequin C.
Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience.
BMC Cancer. 2008 Jan 29;8:26. doi: 10.1186/1471-2407-8-26.
Source | Abstract | Full text | Similar articles